A Study to Assess Antibody Persistence, Boostability & Safety in Previously Primed Subjects.

Clinical trial NCT00317174 · COMPLETED

Trial details

NCT number: NCT00317174
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Haemophilus Influenzae Type b Tetanus Whole Cell Pertussis Hepatitis B Diphtheria

Start date: 2003-07-01
Enrollment: 450

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.